Nairo Quintana’s Tour de France tramadol disqualification upheld

CAS uphold the UCI decision to disqualify the Colombian after painkiller detected in blood tests

Nairo Quintana
(Image credit: Getty)

The decision to disqualify Nairo Quintana from the 2022 Tour de France by the UCI has been upheld by the Court of Arbitration for Sport [CAS]. 

Quintana returned a positive test during the race for tramadol on two separate occasions.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Tom joined Cycling Weekly in early 2022 and his news stories, rider interviews and features appear both online and in the magazine. 


He has reported from some of professional cycling's biggest races and events including the Tour de France and the recent Glasgow World Championships. He has also covered races elsewhere across the world and interviewed some of the sport's top riders. 


When not writing news scoops from the WorldTour, or covering stories from elsewhere in the domestic professional scene, he reports on goings on at bike shops up and down the UK, where he is based when not out on the road at races. He has also appeared on the Radio Cycling podcast.